Skip to main content

Table 1 Correlation between circNOL10 expression and clinicopathological features in 60 breast cancer patients

From: CircNOL10 suppresses breast cancer progression by sponging miR-767-5p to regulate SOCS2/JAK/STAT signaling

Variable circNOL10 expression P value
Low (n = 30) High (n = 30)  
Age    0.573
 ≤ 50 10 8  
 > 50 20 22  
Tumor size    0.018*
 < 2 cm 8 17  
 ≥ 2 cm 22 13  
TNM stage    0.007*
 I–II 14 24  
 III–IV 16 6  
Lymph node metastasis    0.038*
 Negative 10 18  
 Positive 20 12  
Menopausal    0.438
 Premenopausal 16 13  
 Postmenopausal 14 17  
ER status    0.432
 Negative 19 16  
 Positive 11 14  
PR status    0.592
 Negative 10 12  
 Positive 20 18  
HER-2 status    0.584
 Negative 9 11  
 Positive 21 19  
  1. The median expression level of circNOL10 was used as the cutoff
  2. P < 0.05 was considered as statistically significant